{"entity":{"type":"insider","cik":"0001611148","url":"/insider/0001611148","json_url":"/insider/0001611148.json","name":"Shandell Jason B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":26,"first":"2016-05-26","last":"2020-02-07","span_basis":"filed_date"},"name_variants":[{"name":"Shandell Jason B.","source":"filing","n_filings":26,"first_seen":"2016-05-26","last_seen":"2020-02-07"}],"transactions":[{"id":3283647,"accession":"0001104659-20-012712","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-20-012712","line_url":"/filing/0001104659-20-012712#line-6","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6853.0,"shares_display":"6,853","price_per_share":19.8832,"price_display":"19.88","price_state":"stated","total_value":136259.5696,"total_display":"136,259.57","total_whole":"136,260","shares_owned_after":138898.0,"shares_owned_after_display":"138,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-07","scope":"insider"},{"id":3283636,"accession":"0001104659-20-012712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-012712","line_url":"/filing/0001104659-20-012712#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21933.0,"shares_display":"21,933","price_per_share":19.8309,"price_display":"19.83","price_state":"stated","total_value":434951.1297,"total_display":"434,951.13","total_whole":"434,951","shares_owned_after":138898.0,"shares_owned_after_display":"138,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-07","scope":"insider"},{"id":3283628,"accession":"0001104659-20-012712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-012712","line_url":"/filing/0001104659-20-012712#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15615.0,"shares_display":"15,615","price_per_share":19.568,"price_display":"19.57","price_state":"stated","total_value":305554.32,"total_display":"305,554.32","total_whole":"305,554","shares_owned_after":138898.0,"shares_owned_after_display":"138,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider"},{"id":3079739,"accession":"0001104659-20-003034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-003034","line_url":"/filing/0001104659-20-003034#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":18.4391,"price_display":"18.44","price_state":"stated","total_value":460977.5,"total_display":"460,977.50","total_whole":"460,978","shares_owned_after":138898.0,"shares_owned_after_display":"138,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":8201393,"accession":"0001104659-19-074973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-074973","line_url":"/filing/0001104659-19-074973#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8205.0,"shares_display":"8,205","price_per_share":19.1295,"price_display":"19.13","price_state":"stated","total_value":156957.5475,"total_display":"156,957.55","total_whole":"156,958","shares_owned_after":138898.0,"shares_owned_after_display":"138,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":8614114,"accession":"0001104659-19-050885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-050885","line_url":"/filing/0001104659-19-050885#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7340.0,"shares_display":"7,340","price_per_share":21.3228,"price_display":"21.32","price_state":"stated","total_value":156509.352,"total_display":"156,509.35","total_whole":"156,509","shares_owned_after":147103.0,"shares_owned_after_display":"147,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":7833804,"accession":"0001104659-19-040219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-040219","line_url":"/filing/0001104659-19-040219#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6615.0,"shares_display":"6,615","price_per_share":20.3074,"price_display":"20.31","price_state":"stated","total_value":134333.451,"total_display":"134,333.45","total_whole":"134,333","shares_owned_after":154443.0,"shares_owned_after_display":"154,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"},{"id":8764473,"accession":"0001104659-19-026484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-026484","line_url":"/filing/0001104659-19-026484#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.97,"price_display":"21.97","price_state":"stated","total_value":219700.0,"total_display":"219,700.00","total_whole":"219,700","shares_owned_after":159947.0,"shares_owned_after_display":"159,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-02","scope":"insider"},{"id":8475902,"accession":"0001104659-19-022341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-022341","line_url":"/filing/0001104659-19-022341#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9478.0,"shares_display":"9,478","price_per_share":20.6667,"price_display":"20.67","price_state":"stated","total_value":195878.9826,"total_display":"195,878.98","total_whole":"195,879","shares_owned_after":159947.0,"shares_owned_after_display":"159,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-16","filed_date":"2019-04-18","scope":"insider"},{"id":7943336,"accession":"0001104659-19-015713","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-19-015713","line_url":"/filing/0001104659-19-015713#line-5","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24508.0,"shares_display":"24,508","price_per_share":20.3379,"price_display":"20.34","price_state":"stated","total_value":498441.2532,"total_display":"498,441.25","total_whole":"498,441","shares_owned_after":160490.0,"shares_owned_after_display":"160,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-18","scope":"insider"},{"id":7943323,"accession":"0001104659-19-015713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-015713","line_url":"/filing/0001104659-19-015713#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7828.0,"shares_display":"7,828","price_per_share":20.3742,"price_display":"20.37","price_state":"stated","total_value":159489.2376,"total_display":"159,489.24","total_whole":"159,489","shares_owned_after":160490.0,"shares_owned_after_display":"160,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-18","scope":"insider"},{"id":8441073,"accession":"0001104659-19-012154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-012154","line_url":"/filing/0001104659-19-012154#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":24.99,"price_display":"24.99","price_state":"stated","total_value":187425.0,"total_display":"187,425.00","total_whole":"187,425","shares_owned_after":168318.0,"shares_owned_after_display":"168,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-01","scope":"insider"},{"id":7860457,"accession":"0001104659-19-009067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-009067","line_url":"/filing/0001104659-19-009067#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7519.0,"shares_display":"7,519","price_per_share":23.99,"price_display":"23.99","price_state":"stated","total_value":180380.81,"total_display":"180,380.81","total_whole":"180,381","shares_owned_after":168318.0,"shares_owned_after_display":"168,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-15","scope":"insider"},{"id":8613779,"accession":"0001104659-19-003418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-003418","line_url":"/filing/0001104659-19-003418","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15497.0,"shares_display":"15,497","price_per_share":22.392686571594503,"price_display":"22.39","price_state":"stated","total_value":347019.4638,"total_display":"347,019.46","total_whole":"347,019","shares_owned_after":168518.0,"shares_owned_after_display":"168,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-25","scope":"insider","n_lines":2},{"id":6751502,"accession":"0001104659-18-071671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-071671","line_url":"/filing/0001104659-18-071671#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16630.0,"shares_display":"16,630","price_per_share":22.44,"price_display":"22.44","price_state":"stated","total_value":373177.2,"total_display":"373,177.20","total_whole":"373,177","shares_owned_after":183815.0,"shares_owned_after_display":"183,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6481129,"accession":"0001104659-18-068857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-068857","line_url":"/filing/0001104659-18-068857","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16015.0,"shares_display":"16,015","price_per_share":20.40928276615673,"price_display":"20.41","price_state":"stated","total_value":326854.6635,"total_display":"326,854.66","total_whole":"326,855","shares_owned_after":183890.0,"shares_owned_after_display":"183,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-14","filed_date":"2018-11-15","scope":"insider","n_lines":2},{"id":6221275,"accession":"0001104659-18-067546","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-18-067546","line_url":"/filing/0001104659-18-067546#line-5","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16095.0,"shares_display":"16,095","price_per_share":20.99,"price_display":"20.99","price_state":"stated","total_value":337834.05,"total_display":"337,834.05","total_whole":"337,834","shares_owned_after":199505.0,"shares_owned_after_display":"199,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-09","scope":"insider"},{"id":6221269,"accession":"0001104659-18-067546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-067546","line_url":"/filing/0001104659-18-067546#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36201.0,"shares_display":"36,201","price_per_share":20.6786,"price_display":"20.68","price_state":"stated","total_value":748585.9986,"total_display":"748,586.00","total_whole":"748,586","shares_owned_after":199505.0,"shares_owned_after_display":"199,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-09","scope":"insider"},{"id":6476462,"accession":"0001104659-18-044882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-044882","line_url":"/filing/0001104659-18-044882#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14399.0,"shares_display":"14,399","price_per_share":16.7666,"price_display":"16.77","price_state":"stated","total_value":241422.2734,"total_display":"241,422.27","total_whole":"241,422","shares_owned_after":199505.0,"shares_owned_after_display":"199,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-11","filed_date":"2018-07-12","scope":"insider"},{"id":6517080,"accession":"0001104659-18-019046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-019046","line_url":"/filing/0001104659-18-019046#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8293.0,"shares_display":"8,293","price_per_share":19.519,"price_display":"19.52","price_state":"stated","total_value":161871.067,"total_display":"161,871.07","total_whole":"161,871","shares_owned_after":224886.0,"shares_owned_after_display":"224,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-20","scope":"insider"},{"id":6517075,"accession":"0001104659-18-019046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-019046","line_url":"/filing/0001104659-18-019046#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11707.0,"shares_display":"11,707","price_per_share":19.3702,"price_display":"19.37","price_state":"stated","total_value":226766.9314,"total_display":"226,766.93","total_whole":"226,767","shares_owned_after":233179.0,"shares_owned_after_display":"233,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6493728,"accession":"0001104659-18-017864","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-017864","line_url":"/filing/0001104659-18-017864#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":20.45,"price_display":"20.45","price_state":"stated","total_value":8180.0,"total_display":"8,180.00","total_whole":"8,180","shares_owned_after":216948.0,"shares_owned_after_display":"216,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-15","scope":"insider"},{"id":6493724,"accession":"0001104659-18-017864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-017864","line_url":"/filing/0001104659-18-017864#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.45,"price_display":"20.45","price_state":"stated","total_value":6135.0,"total_display":"6,135.00","total_whole":"6,135","shares_owned_after":216948.0,"shares_owned_after_display":"216,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":6140741,"accession":"0001104659-18-004329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-004329","line_url":"/filing/0001104659-18-004329#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9966.0,"shares_display":"9,966","price_per_share":19.559,"price_display":"19.56","price_state":"stated","total_value":194924.994,"total_display":"194,924.99","total_whole":"194,925","shares_owned_after":216948.0,"shares_owned_after_display":"216,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-26","filed_date":"2018-01-26","scope":"insider"},{"id":6140738,"accession":"0001104659-18-004329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-004329","line_url":"/filing/0001104659-18-004329#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8661.0,"shares_display":"8,661","price_per_share":19.2613,"price_display":"19.26","price_state":"stated","total_value":166822.1193,"total_display":"166,822.12","total_whole":"166,822","shares_owned_after":226914.0,"shares_owned_after_display":"226,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-25","filed_date":"2018-01-26","scope":"insider"},{"id":4813476,"accession":"0001104659-17-037042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-037042","line_url":"/filing/0001104659-17-037042#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3654.0,"shares_display":"3,654","price_per_share":17.2606,"price_display":"17.26","price_state":"stated","total_value":63070.2324,"total_display":"63,070.23","total_whole":"63,070","shares_owned_after":237688.0,"shares_owned_after_display":"237,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-31","filed_date":"2017-06-01","scope":"insider"},{"id":4813473,"accession":"0001104659-17-037042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-037042","line_url":"/filing/0001104659-17-037042#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7828.0,"shares_display":"7,828","price_per_share":16.7642,"price_display":"16.76","price_state":"stated","total_value":131230.1576,"total_display":"131,230.16","total_whole":"131,230","shares_owned_after":241342.0,"shares_owned_after_display":"241,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-30","filed_date":"2017-06-01","scope":"insider"},{"id":2069088,"accession":"0001104659-16-159635","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-159635","line_url":"/filing/0001104659-16-159635#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24292.0,"shares_display":"24,292","price_per_share":20.4677,"price_display":"20.47","price_state":"stated","total_value":497201.3684,"total_display":"497,201.37","total_whole":"497,201","shares_owned_after":202961.0,"shares_owned_after_display":"202,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2016-11-29","scope":"insider"},{"id":2069083,"accession":"0001104659-16-159635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-159635","line_url":"/filing/0001104659-16-159635#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2043.0,"shares_display":"2,043","price_per_share":20.5858,"price_display":"20.59","price_state":"stated","total_value":42056.7894,"total_display":"42,056.79","total_whole":"42,057","shares_owned_after":202961.0,"shares_owned_after_display":"202,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-25","filed_date":"2016-11-29","scope":"insider"},{"id":2906736,"accession":"0001104659-16-146915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-146915","line_url":"/filing/0001104659-16-146915#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56996.0,"shares_display":"56,996","price_per_share":19.4973,"price_display":"19.50","price_state":"stated","total_value":1111268.1108,"total_display":"1,111,268.11","total_whole":"1,111,268","shares_owned_after":202961.0,"shares_owned_after_display":"202,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-27","scope":"insider"},{"id":3111096,"accession":"0001104659-16-141236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-141236","line_url":"/filing/0001104659-16-141236#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.95,"price_display":"19.95","price_state":"stated","total_value":199500.0,"total_display":"199,500.00","total_whole":"199,500","shares_owned_after":202961.0,"shares_owned_after_display":"202,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-24","scope":"insider"},{"id":3316100,"accession":"0001104659-16-140755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-140755","line_url":"/filing/0001104659-16-140755#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President and General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5987.0,"shares_display":"5,987","price_per_share":18.859,"price_display":"18.86","price_state":"stated","total_value":112908.833,"total_display":"112,908.83","total_whole":"112,909","shares_owned_after":202961.0,"shares_owned_after_display":"202,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-17","filed_date":"2016-08-19","scope":"insider"},{"id":2200896,"accession":"0000899243-16-027176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-027176","line_url":"/filing/0000899243-16-027176#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5636.0,"shares_display":"5,636","price_per_share":18.0061,"price_display":"18.01","price_state":"stated","total_value":101482.3796,"total_display":"101,482.38","total_whole":"101,482","shares_owned_after":208948.0,"shares_owned_after_display":"208,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-11","filed_date":"2016-08-15","scope":"insider"},{"id":2267939,"accession":"0000899243-16-022670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-022670","line_url":"/filing/0000899243-16-022670#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9904.0,"shares_display":"9,904","price_per_share":16.43,"price_display":"16.43","price_state":"stated","total_value":162722.72,"total_display":"162,722.72","total_whole":"162,723","shares_owned_after":216610.0,"shares_owned_after_display":"216,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-09","filed_date":"2016-06-13","scope":"insider"},{"id":2416322,"accession":"0000899243-16-021086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-021086","line_url":"/filing/0000899243-16-021086#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001611148","owner_name":"Shandell Jason B.","owner_display_name":"Shandell Jason B.","owner_url":"/insider/0001611148","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1074.0,"shares_display":"1,074","price_per_share":15.6,"price_display":"15.60","price_state":"stated","total_value":16754.4,"total_display":"16,754.40","total_whole":"16,754","shares_owned_after":226514.0,"shares_owned_after_display":"226,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001297184","name":"Amphastar Pharmaceuticals, Inc.","url":"/issuer/0001297184","role":"Director, Officer (President and General Counsel)","n_filings":26,"first_seen":"2016-05-26","last_seen":"2020-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001611148","retrieved_at":"2026-08-24T02:07:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}